Psoriatic arthritis
Seronegative inflammatory arthritis associated with psoriasis
Overview
An inflammatory arthritis associated with psoriasis (which may precede, accompany or follow the joint disease). It has several patterns — including a DIP-predominant form, asymmetrical oligoarthritis, a symmetrical RA-like polyarthritis, spondylitis, and the destructive arthritis mutilans. Dactylitis, enthesitis and nail changes are clues.
Recognise
- Joint pain/swelling with psoriasis (skin or nail); DIP-joint involvement, dactylitis ('sausage digit'), enthesitis
- Nail changes: pitting, onycholysis; X-ray 'pencil-in-cup' deformity; arthritis mutilans (telescoping digits) in severe disease
- Several patterns: DIP, asymmetrical oligoarthritis, symmetrical (RA-like), spondylitis, arthritis mutilans
Red flags
- Arthritis mutilans (rapidly destructive) → urgent rheumatology and aggressive therapy
- Psoriatic disease + new inflammatory back pain → axial involvement
Differentials & how to tell them apart

Psoriatic arthritis — erosive change of the interphalangeal joints (hand X-ray)
Cecco / Public domain — Wikimedia Commons
Investigations
Clinical (psoriasis + inflammatory arthritis); usually RF/anti-CCP negative; X-rays (DIP erosions, 'pencil-in-cup', osteolysis); raised inflammatory markers; screen skin/nails; PEST screening tool in psoriasis clinics.
Management
NSAIDs/intra-articular steroid → methotrexate for peripheral disease → biologic if refractory
- 1Diagnose from psoriasis + inflammatory arthritis (dactylitis/enthesitis/nail change). Mild peripheral disease → NSAIDs ± intra-articular steroid; persistent → methotrexate (which also treats the skin).Gate: Axial or arthritis-mutilans disease responds poorly to conventional DMARDs → escalate to a biologic (anti-TNF/IL-17).
- 2Inadequate response or severe/axial disease → biologic or targeted synthetic DMARD; coordinate skin and joint care with dermatology.
Key points
Inflammatory arthritis + psoriasis + dactylitis/nail pitting + DIP involvement + 'pencil-in-cup' = psoriatic arthritis → methotrexate for peripheral disease (treats skin too), biologic for axial/severe. Often RF-negative.
Monitor & prognosis
Joint and skin activity, X-ray progression, biologic safety screen.
Variable; early treatment limits the destructive forms.
Source: NICE NG65 (spondyloarthritis); cross-ref dermatology (psoriasis)